Multiple myeloma. New approaches to therapy.
Dunbar
C E
CE
Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Md, National Institutes of Health 20892.
Nienhuis
A W
AW
D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005819:Genetic Markers; D015316:Genetic Therapy / Q000379:methods; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015850:Interleukin-6 / Q000378:metabolism; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D012106:Research; D014182:Transplantation, Autologous; D014916:Whole-Body Irradiation
D005819:Genetic Markers; D016898:Interferon-alpha; D015850:Interleukin-6; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide; D008558:Melphalan; D005472:Fluorouracil